Notice: This company has been marked as potentially delisted and may not be actively trading. Ritter Pharmaceuticals (RTTR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends RTTR vs. TYRA, SEPN, AVDL, PLRX, BCAX, PRTA, DNTH, CRMD, QURE, and ETNBShould you be buying Ritter Pharmaceuticals stock or one of its competitors? The main competitors of Ritter Pharmaceuticals include Tyra Biosciences (TYRA), Septerna (SEPN), Avadel Pharmaceuticals (AVDL), Pliant Therapeutics (PLRX), Bicara Therapeutics (BCAX), Prothena (PRTA), Dianthus Therapeutics (DNTH), CorMedix (CRMD), uniQure (QURE), and 89bio (ETNB). These companies are all part of the "medical" sector. Ritter Pharmaceuticals vs. Tyra Biosciences Septerna Avadel Pharmaceuticals Pliant Therapeutics Bicara Therapeutics Prothena Dianthus Therapeutics CorMedix uniQure 89bio Ritter Pharmaceuticals (NASDAQ:RTTR) and Tyra Biosciences (NASDAQ:TYRA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Which has preferable earnings & valuation, RTTR or TYRA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRitter PharmaceuticalsN/AN/A-$10.13MN/AN/ATyra BiosciencesN/AN/A-$69.13M-$1.61-9.88 Do institutionals and insiders hold more shares of RTTR or TYRA? 0.8% of Ritter Pharmaceuticals shares are owned by institutional investors. Comparatively, 84.1% of Tyra Biosciences shares are owned by institutional investors. 15.4% of Ritter Pharmaceuticals shares are owned by company insiders. Comparatively, 15.4% of Tyra Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor RTTR or TYRA? In the previous week, Tyra Biosciences had 2 more articles in the media than Ritter Pharmaceuticals. MarketBeat recorded 2 mentions for Tyra Biosciences and 0 mentions for Ritter Pharmaceuticals. Tyra Biosciences' average media sentiment score of 0.42 beat Ritter Pharmaceuticals' score of 0.00 indicating that Tyra Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Ritter Pharmaceuticals Neutral Tyra Biosciences Neutral Does the MarketBeat Community prefer RTTR or TYRA? Ritter Pharmaceuticals received 269 more outperform votes than Tyra Biosciences when rated by MarketBeat users. However, 75.00% of users gave Tyra Biosciences an outperform vote while only 70.23% of users gave Ritter Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRitter PharmaceuticalsOutperform Votes30270.23% Underperform Votes12829.77% Tyra BiosciencesOutperform Votes3375.00% Underperform Votes1125.00% Do analysts prefer RTTR or TYRA? Tyra Biosciences has a consensus target price of $30.50, suggesting a potential upside of 91.70%. Given Tyra Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Tyra Biosciences is more favorable than Ritter Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ritter Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is RTTR or TYRA more profitable? Ritter Pharmaceuticals' return on equity of 0.00% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Ritter PharmaceuticalsN/A N/A -162.05% Tyra Biosciences N/A -24.56%-23.31% Which has more volatility and risk, RTTR or TYRA? Ritter Pharmaceuticals has a beta of -0.43, indicating that its share price is 143% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. SummaryTyra Biosciences beats Ritter Pharmaceuticals on 9 of the 13 factors compared between the two stocks. Get Ritter Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RTTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTTR vs. The Competition Export to ExcelMetricRitter PharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$187.84M$6.58B$5.40B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E Ratio-6.3610.0188.8317.53Price / SalesN/A335.371,284.8780.52Price / CashN/A22.6336.6032.90Price / Book40.705.084.964.69Net Income-$10.13M$154.90M$117.89M$224.57M Ritter Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTTRRitter PharmaceuticalsN/A$4.07+1.8%N/A+711.1%$187.84MN/A-6.367TYRATyra Biosciences2.4829 of 5 stars$15.10-0.7%$30.50+102.0%+23.3%$764.11MN/A-9.3820SEPNSepterna1.6562 of 5 stars$17.00-5.5%$43.67+156.9%N/A$754.85M$981,000.000.00N/AAVDLAvadel Pharmaceuticals3.5705 of 5 stars$7.82-1.0%$21.00+168.5%-48.3%$753.55M$138.16M-9.9070Gap UpPLRXPliant Therapeutics3.7844 of 5 stars$11.77-2.0%$40.50+244.1%-32.9%$716.25M$1.58M-3.5290BCAXBicara TherapeuticsN/A$12.99-9.7%$43.00+231.0%N/A$706.86MN/A0.0032News CoveragePRTAProthena2.4297 of 5 stars$13.13+0.6%$46.50+254.2%-58.3%$706.51M$133.35M-5.29130Positive NewsDNTHDianthus Therapeutics1.9158 of 5 stars$23.04-4.8%$46.43+101.5%+67.4%$681.92M$5.37M-9.2280Short Interest ↑CRMDCorMedix2.4559 of 5 stars$11.12-0.6%$15.67+40.9%+273.3%$674.73M$12.26M-13.7330QUREuniQure4.0524 of 5 stars$13.79-0.4%$33.88+145.6%+153.2%$672.17M$28.59M-2.78500Analyst ForecastPositive NewsETNB89bio2.1502 of 5 stars$6.31-3.1%$30.33+380.7%-42.8%$669.66MN/A-2.1740Analyst ForecastShort Interest ↑News Coverage Related Companies and Tools Related Companies Tyra Biosciences Competitors Septerna Competitors Avadel Pharmaceuticals Competitors Pliant Therapeutics Competitors Bicara Therapeutics Competitors Prothena Competitors Dianthus Therapeutics Competitors CorMedix Competitors uniQure Competitors 89bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RTTR) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ritter Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ritter Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RTTR Stock Alerts